Physician profile
Christopher Kenneth Johnson
NPI 1407086283
$498.00
in general payments reported to CMS, 2019-2025
8 companies · $98.28 in 2025
The $98.28 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $7.64 · 2022: $58.85 · 2023: $102 · 2024: $231 · 2025: $98.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $126.65 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $121.62 | 2024 | Sternalock Blu System |
| E.R. Squibb & Sons, L.L.C. | $98.28 | 2025 | Camzyos |
| Abbott Laboratories | $77.25 | 2023-2024 | Freestyle Libre 3 |
| Indivior INC. | $25.76 | 2024 | Sublocade |
| Xeris Pharmaceuticals, INC. | $24.50 | 2024 | Gvoke Hypopen |
| Organon LLC | $16.30 | 2023 | Nexplanon |
| Travere Therapeutics, INC. | $7.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.